… identification of potential problems, with clear recommendations on how to handle these if
… set of clinical recommendations for each of beta-blockers, ACE inhibitors and spironolactone…

… There are no existing guidelines supporting the … –angiotensin–aldosterone system (RAAS)
antagonists in the preoperative setting. RAAS antagonists include ACE inhibitors, angiotensin …

… recommended in international guidelines, renin-angiotensin-aldosterone system antagonists
[angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs)…

… a large gap between recommendations in guidelines and real-world practice in the use of
… Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial …

… Consistent fair- to good-quality evidence showed that ACE inhibitors were … for ACE
inhibitors, although this evidence was not definitive. Patient subgroups for whom ACE inhibitors or …

… -converting enzyme (ACE) inhibitors and the selective AT1 receptor blockers (ARBs). …
National HF guidelines vary in their recommendations regarding whether ACEIs or ARBs should …

… Current practice guidelines recommend the perioperative … in patients receiving angiotensin
system blockers has been debated ( … sufficient advantage to be routinely recommended ( 29 ). …

… In particular, agents that affect the renin-angiotensin system (RAS), including angiotensin-converting
enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), have demon…

… Second, we address the question of whether the evidence cited in contemporary US practice
guidelines advocating the use of ACE inhibitors or ARBs in chronic kidney disease can be …

… blockers [ACE inhibitors (ACEIs) and angiotensin receptor … The current paper reviews the
latest evidence of isolated … RAAS inhibitors commonly used in clinical practice. Recently, an …